LARIMAR THERAPEUTICS
6.7000
08-10月-24 10:33:03
15 分の遅延
株式
+0.2200
+3.40%
本日の幅
6.4500 - 6.7000
ISIN
N/A
ソース
NASDAQ
-
19 9 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
Larimar Therapeutics to Participate in Upcoming Investor Conferences
27 8 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
Larimar Therapeutics Reports Second Quarter 2024 Operating and Financial Results
07 8 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
30 5 2024 16:05:00 提供 Nasdaq GlobeNewswire
-
20 5 2024 16:05:00 提供 Nasdaq GlobeNewswire
-
Larimar Therapeutics Reports First Quarter 2024 Operating and Financial Results
09 5 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
14 3 2024 16:05:00 提供 Nasdaq GlobeNewswire
-
11 3 2024 16:05:00 提供 Nasdaq GlobeNewswire
-
Larimar Therapeutics to Present at the Leerink Partners Global Biopharma Conference
06 3 2024 16:05:00 提供 Nasdaq GlobeNewswire
-
16 2 2024 16:20:00 提供 Nasdaq GlobeNewswire
-
Larimar Therapeutics Announces Pricing of Underwritten Public Offering of Common Stock
14 2 2024 06:15:00 提供 Nasdaq GlobeNewswire
-
Larimar Therapeutics Announces Proposed Underwritten Public Offering
13 2 2024 16:18:34 提供 Nasdaq GlobeNewswire
-
12 2 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
Larimar Therapeutics Reports Third Quarter 2023 Operating and Financial Results
14 11 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
01 11 2023 16:05:00 提供 Nasdaq GlobeNewswire
-
Larimar Therapeutics Appoints Dr. Jeffery W. Sherman to its Board of Directors
03 10 2023 16:05:00 提供 Nasdaq GlobeNewswire
-
Larimar Therapeutics to Present at the Citi 18th Annual BioPharma Conference
31 8 2023 16:05:00 提供 Nasdaq GlobeNewswire
-
Larimar Therapeutics Reports Second Quarter 2023 Operating and Financial Results
10 8 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
Larimar Therapeutics Appoints Dr. Rusty Clayton as Chief Medical Officer
17 7 2023 16:05:00 提供 Nasdaq GlobeNewswire
-
Larimar Therapeutics Set to Join Russell 3000® Index
21 6 2023 16:05:00 提供 Nasdaq GlobeNewswire
- <<
- <
- 1
- >